MENS (Jyong Biotech) Future Price to Earnings

Official company branding of Jyong Biotech (MENS)

Jyong Biotech Ltd's efficient distribution of pharmaceutical substances, combined with the neutral status of plant-based dietary supplements, provides access to global markets. This chart of the company's forward P/E visualizes the dynamics of market expectations, where 0.00 shows the current value of the metric. However, global fragmentation and sanctions may hinder the conduct of international clinical trials, creating certain risks for business development.

jyongbio.com - MENS Market Cap to Future Earnings Ratio (period 06/18/2025 - 11/16/2026)

Summary analytical data breakdowns for jyongbio.com (MENS)

- current price and projected stock value:
Fundamental valuation:MENS Jyong Biotech
Brand item of Jyong Biotech Ltd

The forward P/E ratio assesses the current share price relative to expected net income, allowing investors to determine the extent of the premium paid for future business growth. By analyzing the forward P/E trend for Jyong Biotech Ltd (MENS) on GURU.Markets, one can evaluate the degree to which the market currently prices in the company's success in sustainable plant-based production and adherence to strict bioethical standards.

Key competitors

Future Price to Earnings haleon.com (HLN)|KVUE (Kenvue Health) - Future Price to Earnings Multiple|Future Price to Earnings Verona Pharma PLC VRNA|Ligand (LGND) - Projected Price to Earnings Ratio|AMRX: Projected Price to Earnings|Perrigo - Market Cap to Future Earnings Ratio|ALVO: Forward P/E Multiple|Liquidia Technologies - Future Price to Earnings Multiple|GLPG (Galapagos N.V.) - Forward P/E Multiple|Projected Price to Earnings Ratio anipharmaceuticals.com ANIP|Future Price to Earnings MannKind (MNKD)|AMPH (Amphastar Pharmaceuticals, Inc.) - Future Price to Earnings Multiple|Future Price to Earnings Pacira BioSciences, Inc. PCRX|Forward P/E Multiple ARS Corp SPRY|Theravance Biopharma - Forward P/E Multiple|Forward Price to Earnings Multiple Aquestive Therapeutics, Inc. (AQST)|scPharmaceuticals (SCPH) - Future Price to Earnings|Projected Price to Earnings Tectonic Therapeutic, Inc.|TNXP (Tonix Pharmaceuticals Holding) - Forward P/E Multiple|Price to Future Earnings Ratio SXTC (China SXT Pharmaceuticals)|Forward P/E Multiple EPRX|Forward P/E Multiple bioharvest.com (BHST)|Future Price to Earnings Invizyne Technologies EXOZ|ORMP: Price to Future Earnings Ratio|ENTX: Projected Price to Earnings|HYFT: Future Price to Earnings|ABVC BioPharma Inc. (ABVC) - Future Price to Earnings|cumberlandpharma.com (CPIX) - Forward P/E Multiple|QNTM (Quantum BioPharma) - Forward P/E Multiple|FGEN: Future Price to Earnings Multiple|Forward P/E Multiple TELO|Forward P/E Multiple Rani Therapeutics Holdings (RANI)|Forward P/E Multiple SNYR (Synergy CHC Corp)|Rallybio Corporation (RLYB) - Projected Price to Earnings Ratio|LEXX - Future Price to Earnings|PULM (Pulmatrix) - Price to Future Earnings Ratio|Pheton Holdings Ltd (PTHL) - Future Price to Earnings|Aptorum - Future Price to Earnings Multiple|Projected Price to Earnings LYRA|Projected Price to Earnings Impact BioMedical Inc (IBO)|Forward P/E Multiple TNFA|YCBD: Price to Expected Earnings Ratio|Future Price to Earnings PainReform PRFX|altamiratherapeutics.com (CYTO) - Projected Price to Earnings Ratio|LIPO: Projected Price to Earnings|OPTN (optinose.com) - Price to Future Earnings Ratio|PIRS: Forward P/E Multiple|PROC - Market Cap to Projected Earnings|PTPI (Petros Pharma) - Forward P/E Multiple|Future Price to Earnings QLI|Forward P/E Multiple SLRN|Market Cap to Future Earnings Ratio TFFP